title: Safety assessment of EPA-rich triglyceride oil produced from yeast: genotoxicity and 28-day oral toxicity in rats.
abstract: The 28-day repeat-dose oral and genetic toxicity of eicosapentaenoic acid triglyceride oil (EPA oil) produced from genetically modified Yarrowia lipolytica yeast were assessed. Groups of rats received 0 (olive oil), 940, 1880, or 2820 mg EPA oil/kg/day, or fish oil (sardine/anchovy source) by oral gavage. Lower total serum cholesterol was seen in all EPA and fish oil groups. Liver weights were increased in the medium and high-dose EPA (male only), and fish oil groups but were considered non-adverse physiologically adaptive responses. Increased thyroid follicular cell hypertrophy was observed in male high-dose EPA and fish oil groups, and was considered to be an adaptive response to high levels of polyunsaturated fatty acids. No adverse test substance-related effects were observed on body weight, nutritional, or other clinical or anatomic pathology parameters. The oil was not mutagenic in the in vitro Ames or mouse lymphoma assay, and was not clastogenic in the in vivo mouse micronucleus test. In conclusion, exposure for 28 days to EPA oil derived from yeast did not produce adverse effects at doses up to 2820 mg/kg/day and was not genotoxic. The safety profile of the EPA oil in these tests was comparable to a commercial fish oil.
authors.affiliation: DuPont Haskell Global Centers for Health & Environmental Sciences, E.I. duPont de Nemours & Company, 1090 Elkton Road, Newark, DE 19711-3507, USA. leigh.a.belcher@usa.dupont.com
authors.forename: Leigh A
authors.initials: LA
authors.lastname: Belcher
authors.forename: Susan A
authors.initials: SA
authors.lastname: MacKenzie
authors.forename: Maria
authors.initials: M
authors.lastname: Donner
authors.forename: Greg P
authors.initials: GP
authors.lastname: Sykes
authors.forename: Steven R
authors.initials: SR
authors.lastname: Frame
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Gillies
mesh_terms: D000284:Administration, Oral; D000818:Animals; D001095:Arachidonic Acids / Q000008:administration & dosage / Q000096:biosynthesis / Q000633:toxicity*; D001835:Body Weight / Q000187:drug effects; D045744:Cell Line, Tumor; D002784:Cholesterol / Q000097:blood; D004435:Eating / Q000187:drug effects; D005260:Female; D005395:Fish Oils / Q000633:toxicity; D006965:Hyperplasia; D008099:Liver / Q000187:drug effects / Q000473:pathology; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D015162:Micronucleus Tests; D009152:Mutagenicity Tests; D009821:Oils / Q000008:administration & dosage / Q000378:metabolism / Q000633:toxicity*; D000069463:Olive Oil; D010938:Plant Oils / Q000633:toxicity; D051381:Rats; D017207:Rats, Sprague-Dawley; D018570:Risk Assessment; D013961:Thyroid Gland / Q000187:drug effects / Q000473:pathology; D013997:Time Factors; D018675:Toxicity Tests; D014280:Triglycerides / Q000008:administration & dosage / Q000096:biosynthesis / Q000633:toxicity*; D025062:Yarrowia / Q000235:genetics / Q000378:metabolism*
chemical_list: D001095:Arachidonic Acids; D005395:Fish Oils; D009821:Oils; D000069463:Olive Oil; D010938:Plant Oils; D014280:Triglycerides; D002784:Cholesterol